Alto Ingredients Q2 2024 GAAP EPS $(0.05) Beats $(0.10) Estimate, Sales $236.468M Beat $232.482M Estimate
Portfolio Pulse from Benzinga Newsdesk
Alto Ingredients (NASDAQ:ALTO) reported Q2 2024 GAAP EPS of $(0.05), beating the $(0.10) estimate. Sales were $236.468M, surpassing the $232.482M estimate but down 25.47% from last year.
August 06, 2024 | 9:03 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Alto Ingredients reported better-than-expected Q2 2024 GAAP EPS of $(0.05) and sales of $236.468M, beating estimates. However, sales decreased by 25.47% compared to the same period last year.
The better-than-expected EPS and sales figures are positive short-term indicators for ALTO's stock price. However, the significant YoY sales decline may temper investor enthusiasm.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100